Skyhawk Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
35 Gatehouse Dr, Waltham, Massachusetts,...Phone Number
(617) 858-0041Website
www.skyhawktx.comRevenue
$9.5 MillionIndustry
About Skyhawk Therapeutics
Skyhawk Therapeutics is dedicated to revolutionizing disease treatment through small molecule therapeutics that modify RNA expression. Their potent drug candidates target RNA to address a wide range of neurodegenerative and challenging diseases. The company focuses on developing orally-administered small molecules that are patient-friendly and have broad biological distribution. Skyhawk aims to leverage its expertise in RNA splicing and machine learning to meet the significant unmet needs of patients worldwide.Explore more
Skyhawk Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Skyhawk Therapeutics
Compare insights from companies similar to Skyhawk Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Skyhawk Therapeutics Tech Stack
A closer look at the technologies used by Skyhawk Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Skyhawk Therapeutics
Sign Up For FreeTo access detailed company insights
Skyhawk Therapeutics is dedicated to revolutionizing disease treatment through small molecule therapeutics that modify RNA expression. Their potent drug candidates target RNA to address a wide range of neurodegenerative and challenging diseases. The company focuses on developing orally-administered small molecules that are patient-friendly and have... Read More
